200 related articles for article (PubMed ID: 29345434)
21. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy.
Cai X; Luo Y; Song Y; Liu D; Yan H; Li H; Du D; Zhu C; Lin Y
Nanoscale; 2018 Dec; 10(48):22937-22945. PubMed ID: 30500027
[TBL] [Abstract][Full Text] [Related]
22. Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells.
Rahmani S; Budimir J; Sejalon M; Daurat M; Aggad D; Vivès E; Raehm L; Garcia M; Lichon L; Gary-Bobo M; Durand JO; Charnay C
Molecules; 2019 Jan; 24(2):. PubMed ID: 30658511
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.
Croissant JG; Fatieiev Y; Julfakyan K; Lu J; Emwas AH; Anjum DH; Omar H; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Oct; 22(42):14806-14811. PubMed ID: 27258139
[TBL] [Abstract][Full Text] [Related]
25. Core-Shell-structured Dendritic Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Antibody Delivery.
Abbaraju PL; Yang Y; Yu M; Fu J; Xu C; Yu C
Chem Asian J; 2017 Jul; 12(13):1465-1469. PubMed ID: 28481442
[TBL] [Abstract][Full Text] [Related]
26. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
27. Cyclodextrin-gated mesoporous silica nanoparticles as drug carriers for red light-induced drug release.
Chai S; Guo Y; Zhang Z; Chai Z; Ma Y; Qi L
Nanotechnology; 2017 Apr; 28(14):145101. PubMed ID: 28281469
[TBL] [Abstract][Full Text] [Related]
28. Upconverting nanoparticles with a mesoporous TiO₂ shell for near-infrared-triggered drug delivery and synergistic targeted cancer therapy.
Yin M; Ju E; Chen Z; Li Z; Ren J; Qu X
Chemistry; 2014 Oct; 20(43):14012-7. PubMed ID: 25200923
[TBL] [Abstract][Full Text] [Related]
29. Phthalocyanine-based mesoporous organosilica nanoparticles: NIR photodynamic efficiency and siRNA photochemical internalization.
Ekineker G; Nguyen C; Bayır S; Dominguez Gil S; İşci Ü; Daurat M; Godefroy A; Raehm L; Charnay C; Oliviero E; Ahsen V; Gary-Bobo M; Durand JO; Dumoulin F
Chem Commun (Camb); 2019 Sep; 55(77):11619-11622. PubMed ID: 31501844
[TBL] [Abstract][Full Text] [Related]
30. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
31. Tailoring cubic and dodecagonal quasicrystalline mesophases of mesoporous organosilica nanoparticles and core/shell structure.
Baipaywad P; Wi JS; Park H; Paik T
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():666-674. PubMed ID: 30813071
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications.
Jain P; Hassan N; Iqbal Z; Dilnawaz F
Recent Pat Drug Deliv Formul; 2018; 12(4):228-237. PubMed ID: 30501606
[TBL] [Abstract][Full Text] [Related]
33. Mesoporous silica nanoparticles in medicine--recent advances.
Mamaeva V; Sahlgren C; Lindén M
Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
[TBL] [Abstract][Full Text] [Related]
34. Silica-based nanoparticles are efficient delivery systems for temoporfin.
Brezániová I; Záruba K; Králová J; Sinica A; Adámková H; Ulbrich P; Poučková P; Hrubý M; Štěpánek P; Král V
Photodiagnosis Photodyn Ther; 2018 Mar; 21():275-284. PubMed ID: 29288831
[TBL] [Abstract][Full Text] [Related]
35. Periodic Mesoporous Organosilica Nanoparticles with Controlled Morphologies and High Drug/Dye Loadings for Multicargo Delivery in Cancer Cells.
Croissant JG; Fatieiev Y; Omar H; Anjum DH; Gurinov A; Lu J; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Jul; 22(28):9607-15. PubMed ID: 27245497
[TBL] [Abstract][Full Text] [Related]
36. Design and Synthesis of Core-Shell-Shell Upconversion Nanoparticles for NIR-Induced Drug Release, Photodynamic Therapy, and Cell Imaging.
Wang H; Han RL; Yang LM; Shi JH; Liu ZJ; Hu Y; Wang Y; Liu SJ; Gan Y
ACS Appl Mater Interfaces; 2016 Feb; 8(7):4416-23. PubMed ID: 26816249
[TBL] [Abstract][Full Text] [Related]
37. Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine.
Er Ö; Colak SG; Ocakoglu K; Ince M; Bresolí-Obach R; Mora M; Sagristá ML; Yurt F; Nonell S
Molecules; 2018 Oct; 23(11):. PubMed ID: 30355983
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Fluorescence Imaging and Photodynamic Cancer Therapy Using Hollow Mesoporous Nanocontainers.
Hong SH; Kim H; Choi Y
Chem Asian J; 2017 Jul; 12(14):1700-1703. PubMed ID: 28463441
[TBL] [Abstract][Full Text] [Related]
39. Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications.
Idris NM; Jayakumar MK; Bansal A; Zhang Y
Chem Soc Rev; 2015 Mar; 44(6):1449-78. PubMed ID: 24969662
[TBL] [Abstract][Full Text] [Related]
40. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
